(UroToday.com) In a session entitled Clearer Vision chaired by Dr. Bertrand Tombal at the 2021 ANZUP Annual Scientific Meeting, Dr. Chris Parker presented on how multiparametric magnetic resonance imaging (MRI) became the mainstay of active surveillance for prostate cancer.